Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial

CONCLUSION: Participants unblinded to their CAC showed reductions in LDL irrespective of statin continuation when compared to controls at 12 months. Improvements in individual risk factors and PCE risk were also noted. CAC assessment may positively influence patients and physicians to improve risk factor control.PMID:34482089 | DOI:10.1016/j.atherosclerosis.2021.08.002

Source: Australian Family Physician - September 5, 2021 Category: Primary Care Authors: Prasanna Venkataraman Quan Huynh Stephen J Nicholls Tony Stanton Gerald F Watts Thomas H Marwick CAUGHT-CAD investigators Source Type: research